Contrast-enhanced Ultrasound Evaluation of Indeterminate Ovarian Lesions: Prospective Multicenter Study

Official record

Identifier

NCT07849543

Recruiting locations

Locations are not included in the offline baseline for this record. Open the official record to see the current site list.

Interventions studied

Contrast-Enhanced Ultrasound (CEUS)

Lead sponsor

Thomas Jefferson University

Target enrolment

190 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Not yet recruiting

First posted

Sep 30, 2026

Last updated on the registry

Sep 30, 2026

Age

18 Years

Sex

FEMALE

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* All subjects accepted for this trial must be:

  * Patients ≥ 18 years of age.
  * Capable of making informed decisions regarding her treatment.
  * Have an ovarian or adnexal lesion categorized as O-RADS US 3-5 on conventional US, OR
  * Have an ovarian or adnexal lesion categorized as O-RADS MRI 3-5 on pelvic MRI

Exclusion Criteria:

* Subjects with any of the following will be excluded from this trial:

  * Patients with physiological or definitely benign ovarian or adnexal lesions (O-RADS 1-2).
  * Patients who are pregnant or lactating.
  * Patients with ovarian or adnexal lesions less than 1 cm or greater than 15 cm in size.
  * Patients with contraindications to CEUS.
  * Patients who are medically unstable, terminally ill, or whose clinical course is unpredictable.

Indexed under

Ovarian Cancer